Biotech

All Articles

Praxis epilepsy medication reduces confiscations in phase 2 litigation

.Practice Precision Medicines has racked up another midphase succeed in epilepsy this year, with its...

Three directors resign as Dyne posts blended information for DMD prospect

.After getting away a professional hold numerous years back, Dyne Therapeutics has disclosed new pha...

Arrowhead fires off period 3 data in uncommon metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its give in advance of a possible showdown along with Ionis...

Pfizer, Valneva show lyme ailment shot successful for second booster

.Pfizer and also Valneva may have regarding 2 more years to wait before they make the first approval...

Fierce Biotech Managing Editor Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a chat with Ayla Ellison, Intense Biotech Managing Editor and Michelle Benz as they...

New data demonstrate how Bayer's asundexian neglected to stop strokes

.Bayer suspended the phase 3 trial for its element XIa inhibitor asundexian behind time in 2013 afte...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its a number of sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund shows intent to form its own advancement

.Galapagos is happening under added tension from clients. Having actually constructed a 9.9% stake i...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and...

Allist settles Jacobio $21M, landing function in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired on its own a starring character in China's KRAS market...